Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation.
Conventional approaches to the treatment of recurrent mantle cell lymphoma (MCL) yield unsatisfactory results. We describe a patient with recurrent MCL in leukemic phase refractory to chemotherapy who was successfully treated with allogeneic bone marrow transplantation. At last follow-up 1 year post-transplant, the patient was in complete remission and had limited chronic graft-versus-host disease.
Adkins
D
D
Washington University School of Medicine, Department of Internal Medicine, Division of Bone Marrow Transplantation, St Louis, MO 63110, USA.
Brown
R
R
Goodnough
L T
LT
Khoury
H
H
Popovic
W
W
DiPersio
J
J
D016026:Bone Marrow Transplantation; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous